NeurAxis (NRXS)

Profile

Full Name

NeurAxis, Inc.

Ticker Symbol

NRXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 9, 2023

Indexes

Not included

Website

http://neuraxis.com

Employees

21

Key Details

Price

$1.73(-3.35%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.69M(+9.18% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.73
NRXS price is $1.73

30-Day Relative Volume

3.09
NRXS 30-day relative volume is 3.09

Price Performance

Price Most recent change

-3.35%
NRXS price was down -3.35% on Apr 14, 2025

Price YTD change

-26.38%
NRXS price is down -26.38% since January 1st

Price 1-year change

-45.43%
NRXS price is down -45.43% year-on-year

Price 3-year change

-
NRXS price 3-year change is unknown

Price Range

Price All-time high

$6.93
NRXS price is currently -75.04% below its historical high of $6.93

Price 3-year low

$1.48
NRXS price is currently +16.89% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.31M
NRXS market capitalization is $9.31 million

Market cap 3-year change

-
NRXS market capitalization 3-year change is unknown

Market cap All-time high

$33.10M
NRXS market capitalization is currently -71.87% below its historical high of $33.10 million

Market cap sector rank

18.91%
NRXS market capitalization is higher than 18.91% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
NRXS {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-
NRXS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
NRXS beta is 0.62

200-day SMA

$2.71
NRXS price is currently -36.19% below its 200-day simple moving average

50-day SMA

$2.18
NRXS price is currently -20.71% below its 50-day simple moving average

RSI

34.93
NRXS 14-day relative strength index is 34.93

Volume

3.09
NRXS 30-day relative volume is 3.09

ATR

$0.31
NRXS average true range is $0.31

10-day Historical Volatility

86.24%
NRXS 10-day historical volatility is 86.24%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.69M
NRXS annual revenue is $2.69 million

Revenue Analysts estimate

$3.66B
NRXS annual revenue is currently -99.93% lower than the consensus analysts' forecast

Revenue 1-year change

+9.18%
NRXS annual revenue is up +9.18% year-on-year

Revenue Sector rank

17.25%
NRXS annual revenue is higher than 17.25% of companies in Healthcare sector

EPS

EPS

-
NRXS annual earnings per share value is unknown

EPS Analysts estimate

-$0.98
NRXS annual earnings per share is currently equal to the consensus analysts' forecast

EPS 1-year change

-
NRXS annual earnings per share 1-year change is unknown

EPS Sector rank

-
NRXS annual earnings per share is unknown

Profit

Gross profit

$2.32M
NRXS annual gross profit is $2.32 million

Gross margin

86.52%
NRXS annual gross profit margin is 86.52%

Operating profit

-$7.16M
NRXS annual operating income is -$7.16 million

Operating margin

-266.46%
NRXS annual operating profit margin is -266.46%

Net income

-$8.24M
NRXS annual net profit is -$8.24 million

Net margin

-
NRXS annual net profit margin value is unknown

Expenses

Total expenses

$9.84M
NRXS annual total expenses is $9.84 million

Operating expenses

$9.48M
NRXS annual total operating expenses is $9.48 million

Cost of goods sold

$362.00K
NRXS annual cost of goods sold is $362.00 thousand

Selling, general & administrative expenses

$9.27M
NRXS annual SGA is $9.27 million

Depreciation and amortization

$37.83K
NRXS annual depreciation & amortization is $37.83 thousand

Interest expense

$300.71K
NRXS annual interest expense is $300.71 thousand

Income tax

-
NRXS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$7.94M
NRXS annual earnings before interest & taxes is -$7.94 million

EBITDA

-$7.90M
NRXS annual EBITDA is -$7.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.76M
NRXS annual total assets is $4.76 million

Non current assets

$491.39K
NRXS annual long term assets is $491.39 thousand

Current assets

$4.27M
NRXS annual total current assets is $4.27 million

Cash and cash equivalents

$3.70M
NRXS annual cash & cash equivalents is $3.70 million

Accounts receivable

$244.62K
NRXS annual accounts receivable is $244.62 thousand

Inventory

$44.33K
NRXS annual inventory is $44.33 thousand

Liabilities

Total liabilities

$2.69M
NRXS annual total liabilities is $2.69 million

Long term liabilities

$256.50K
NRXS annual total long term liabilities is $256.50 thousand

Current liabilities

$2.43M
NRXS annual total current liabilities is $2.43 million

Accounts payable

$596.95K
NRXS annual accounts payable is $596.95 thousand

Debt

Total debt

$473.40K
NRXS annual total debt is $473.40 thousand

Total debt 1-year change

+111.1%
NRXS annual total debt is up +111.1% year-on-year

Long term debt

$256.50K
NRXS annual long term debt is $256.50 thousand

Short term debt

$154.15K
NRXS annual short term debt is $154.15 thousand

Equity & Capital

Shareholders equity

$2.07M
NRXS annual stockholders equity is $2.07 million

Book value

$1.97M
NRXS annual book value is $1.97 million

Retained earnings

-$56.80M
NRXS annual retained earnings is -$56.80 million

Working capital

$1.83M
NRXS annual working capital is $1.83 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.10M
NRXS annual cash flow from operations is -$6.10 million

Cash from operations 1-year change

+8.9%
NRXS annual cash flow from operations is up +8.9% year-on-year

Cash from investing

-$27.78K
NRXS annual cash flow from investing activities is -$27.78 thousand

Cash from investing 1-year change

+61.3%
NRXS annual cash flow from investing activities is up +61.3% year-on-year

Cash from financing

$9.74M
NRXS annual cash flow from financing activities is $9.74 million

Cash from financing 1-year change

+48.3%
NRXS annual cash flow from financing activities is up +48.3% year-on-year

CAPEX

CAPEX

$27.78K
NRXS annual capital expenditures is $27.78 thousand

CAPEX 1-year change

-61.3%
NRXS annual capital expenditures is down -61.3% year-on-year

Free Cash Flow

Free cash flow

-$6.13M
NRXS annual free cash flow is -$6.13 million

Free cash flow 1-year change

+9.46%
NRXS annual free cash flow is up +9.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

86.52%
NRXS annual gross profit margin is 86.52%

Operating margin

-266.46%
NRXS annual operating profit margin is -266.46%

Net margin

-
NRXS annual net profit margin value is unknown

ROA & ROE

ROA

-173.23%
NRXS annual return on assets is -173.23%

ROE

-398.57%
NRXS annual return on equity is -398.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NRXS price to earnings ratio value is unknown

PE ratio Sector rank

-
NRXS price to earnings ratio is unknown

PB Ratio

PB ratio

4.73
NRXS price to book ratio is 4.73

PB ratio Sector rank

82.39%
NRXS price to book ratio is higher than 82.39% of companies in Healthcare sector

PS Ratio

PS ratio

3.47
NRXS price to sales ratio is 3.47

PS ratio Sector rank

57.44%
NRXS price to sales ratio is higher than 57.44% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.09M
NRXS enterprise value is $6.09 million

Enterprise value Sector rank

20.66%
NRXS enterprise value is higher than 20.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.77
NRXS EV/EBITDA is -0.77

EV/EBITDA Sector rank

46.96%
NRXS EV/EBITDA is higher than 46.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.75
NRXS annual current ratio is 1.75

Quick ratio

1.74
NRXS annual quick ratio is 1.74

Leverage

Debt to equity

0.23
NRXS annual debt to equity ratio is 0.23

Interest coverage ratio

-26.41
NRXS annual interest coverage ratio is -26.41

Risk & Stability

Piotroski F-Score

3
NRXS piotroski f-score is 3

Altman Z-Score

-19.12
NRXS altman z-score is -19.12

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

HCWB logo
HCW Biologics (HCWB)
EKSO logo
Ekso Bionics Holdings (EKSO)
MGRX logo
Mangoceuticals (MGRX)
HOOK logo
HOOKIPA Pharma (HOOK)
COSCIENS Biopharma (CSCI)
Neuphoria Therapeutics (NEUP)
BCDA logo
BioCardia (BCDA)
BIAF logo
bioAffinity Technologies (BIAF)
NURO logo
NeuroMetrix (NURO)
  • What is the ticker symbol for NeurAxis?
  • Does NeurAxis pay dividends?
  • What sector is NeurAxis in?
  • What industry is NeurAxis in?
  • What country is NeurAxis based in?
  • When did NeurAxis go public?
  • Is NeurAxis in the S&P 500?
  • Is NeurAxis in the NASDAQ 100?
  • Is NeurAxis in the Dow Jones?
  • When does NeurAxis report earnings?
  • Should I buy NeurAxis stock now?

What is the ticker symbol for NeurAxis?

The ticker symbol for NeurAxis is NASDAQ:NRXS

Does NeurAxis pay dividends?

No, NeurAxis does not pay dividends

What sector is NeurAxis in?

NeurAxis is in the Healthcare sector

What industry is NeurAxis in?

NeurAxis is in the Biotechnology industry

What country is NeurAxis based in?

NeurAxis is headquartered in United States

When did NeurAxis go public?

NeurAxis's initial public offering (IPO) was on August 9, 2023

Is NeurAxis in the S&P 500?

No, NeurAxis is not included in the S&P 500 index

Is NeurAxis in the NASDAQ 100?

No, NeurAxis is not included in the NASDAQ 100 index

Is NeurAxis in the Dow Jones?

No, NeurAxis is not included in the Dow Jones index

When does NeurAxis report earnings?

The date for NeurAxis's next earnings report has not been announced yet

Should I buy NeurAxis stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page